StonvexLoading…
StonvexStonvexStonvexCore line items from PTRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $773.73M | $2.50B | $1.78B | $540.41M |
Operating Income | $39.57M | $25.41M | $-642.00K | $29.41M |
Net Income | $29.21M | $16.25M | $-12.48M | $22.80M |
EPS (Diluted) | $0.16 | $-1.36 | $-1.96 | $0.17 |
Total Assets | $967.20M | $947.64M | $843.11M | Not available |
Total Liabilities | $357.51M | $366.64M | $301.74M | Not available |
Cash & Equivalents | $344.22M | $289.05M | $312.80M | $218.78M |
Free Cash Flow OCF − CapEx | $63.32M | $78.92M | $75.71M | $43.17M |
Shares Outstanding | 179.46M | 115.00M | 94.35M | 90.59M |